In the quiet architecture of memory, a team of USC neuroscientists has found that depression leaves a measurable imprint on a specific chamber of the hippocampus — the CA23DG subfield, responsible for retrieving memories and telling similar experiences apart. Studying over two thousand older adults, they discovered this structural difference persists even after accounting for the known biological signatures of Alzheimer's disease, suggesting depression carves its path through the brain by its own distinct routes. The finding does not yet tell us whether depression causes this shrinkage or what
Depression linked to shrinkage in specific hippocampal region, study finds
Depression targets a particular set of subfields
Mark
Why does it matter that the shrinkage is concentrated in CA23DG and not the whole hippocampus?
Mimi
Because it tells us depression isn't just a general brain-shrinking condition. It's targeting something specific. CA23DG handles memory retrieval and pattern separation—distinguishing between similar experiences. If depression is selectively damaging that function, it might explain why depressed people sometimes struggle with memory in particular ways.
Mark
So this finding is separate from Alzheimer's?
Mimi
Partly. Depression increases dementia risk, but this study suggests the mechanism may be different from the amyloid and tau buildup we see in Alzheimer's. Depression might be damaging the hippocampus through its own pathway. That's a crucial distinction for treatment.
Mark
What about the antidepressant finding? Should people be worried?
Mimi
No. The researchers were very clear about this. They can't tell if the medication caused the difference or if people on medication simply had more severe depression to begin with. Without knowing depression duration, severity before treatment, or how long people took drugs, you can't draw conclusions. They explicitly said not to change medication based on this.
Mark
Why is this study more trustworthy than previous ones?
Mimi
Two reasons. First, they used high-resolution imaging to look at subfields instead of treating the hippocampus as one blob. Second, the population was large—over 2,000 people—and diverse across racial and ethnic lines. That's more representative of actual aging in America.
Mark
What's the next step?
Mimi
Long-term studies. Following people over time, tracking when depression starts, how severe it gets, what treatment they receive, and how their brains change. That's the only way to separate cause from correlation and understand whether treating depression early might protect hippocampal volume.
El Pulso
- Depression has long been suspected of reshaping the brain, but until now researchers lacked the resolution to say exactly where — this study pins the damage to a single hippocampal subfield, CA23DG, while leaving neighboring regions untouched.
- The stakes are high: depression is already known to raise Alzheimer's risk, and identifying a structural brain change independent of amyloid, tau, and genetic risk factors suggests the two diseases may be connected by pathways science has not yet mapped.
- A complicating signal emerged when participants on antidepressants showed even smaller brain volumes — a finding the researchers refused to sensationalize, noting that sicker patients are the ones most likely to be prescribed medication in the first place.
- The study's strength lies in its scale and diversity, drawing from a community-based cohort of Hispanic, non-Hispanic Black, and non-Hispanic White adults, making its findings more broadly applicable than much prior research in this field.
- The path forward remains uncharted: causality is unproven, depression histories were incomplete, and the long-term studies needed to track these changes over time — before and after treatment, across symptom severity — have yet to be done.
In the quiet architecture of memory, a team of USC neuroscientists has found that depression leaves a measurable imprint on a specific chamber of the hippocampus — the CA23DG subfield, responsible for retrieving memories and telling similar experiences apart. Studying over two thousand older adults, they discovered this structural difference persists even after accounting for the known biological signatures of Alzheimer's disease, suggesting depression carves its path through the brain by its own distinct routes. The finding does not yet tell us whether depression causes this shrinkage or what it ultimately means for dementia risk, but it offers a precise anatomical landmark in a landscape that has long resisted such clarity.
A USC neuroscience team has located a specific site in the brain where depression appears to leave its mark. Using high-resolution MRI scans of 2,009 cognitively healthy adults aged 50 to 90, they found that people with depression had measurably smaller volume in a hippocampal subfield called CA23DG — a region central to memory retrieval and the ability to distinguish between similar experiences. Two neighboring subfields, CA1 and the subiculum, showed no such difference.
What gives the finding particular weight is what it survived. The researchers used PET imaging to measure amyloid and tau proteins — the hallmarks of Alzheimer's disease — and also accounted for the APOE ε4 genetic risk variant. Even after controlling for all three, the link between depression and CA23DG shrinkage held. This suggests depression may damage hippocampal structure through biological mechanisms that run parallel to, rather than through, the pathways driving Alzheimer's disease.
One signal demanded careful handling. Among depressed participants, those taking antidepressants showed smaller volumes in both CA1 and CA23DG compared to those not on medication. The researchers were quick to caution against misreading this: medication data came from self-report, and there was no information on how long participants had been depressed or how severe their symptoms were before treatment began. Lead author Danielle Luu noted plainly that more severe depression — the kind that gets treated — may itself be responsible for the structural differences. The team stressed that the findings should not discourage anyone from taking prescribed medication.
The study drew from HABS-HD, a diverse community-based initiative examining Alzheimer's risk across multiple ethnic groups, lending the findings a breadth uncommon in brain aging research. Still, the researchers were explicit about the limits of what they had shown: no causal link was established, and no direct path to dementia was proven. Arthur Toga, director of the Stevens INI, framed the work as a beginning — a precise anatomical clue that may eventually help identify people at risk and guide more personalized approaches to brain health, once the longer, more detailed studies that this discovery now calls for are finally undertaken.
A team of neuroscientists at USC has identified a precise location in the brain where depression leaves its mark. Using high-resolution MRI scans, they found that people with depression show measurably smaller volume in a specific hippocampal region called CA23DG—an area that plays a crucial role in retrieving memories and distinguishing between similar experiences. The discovery, published in Translational Psychiatry, comes from an analysis of 2,009 cognitively healthy adults between 50 and 90 years old, of whom 630 had depression and 1,379 did not.
The hippocampus has long fascinated neuroscientists because it sits at the intersection of memory, learning, and aging. But treating it as a single structure can mask what's actually happening in its smaller subdivisions. The USC team used advanced imaging to measure three distinct areas: CA1, which helps the brain recognize new information and connect it to existing knowledge; the subiculum, which acts as a relay station sending information from the hippocampus outward; and CA23DG, the combined region encompassing CA2, CA3, and the dentate gyrus. Each performs different functions. Each may respond differently to depression, aging, and disease. The researchers found that depression correlated with smaller volume specifically in CA23DG—but not in the other two regions. This precision matters. It suggests depression doesn't simply shrink the entire hippocampus uniformly. It targets a particular set of subfields.
What makes this finding especially significant is what it rules out. Depression has long been known to increase the risk of Alzheimer's disease, but the biological mechanism has remained murky. The USC team used PET scans to measure amyloid and tau, the two proteins that accumulate abnormally in Alzheimer's brains. They also checked for APOE ε4, a genetic variant linked to higher dementia risk. When they accounted for all three of these established Alzheimer's risk factors, the relationship between depression and CA23DG shrinkage remained intact. This suggests depression may damage hippocampal structure through pathways that are at least partly independent of the mechanisms driving Alzheimer's disease—a distinction that could reshape how researchers think about the depression-dementia connection.
One finding warrants caution. Among people with depression, those taking antidepressant medication showed smaller volumes in both CA1 and CA23DG compared to those not on medication. But the researchers were careful not to overstate this. They noted that medication information came from participant reports rather than medical records, and they had no data on how long people had been depressed, how severe their symptoms were before treatment, or how long they'd taken drugs. People prescribed antidepressants may simply have experienced more severe or longer-lasting depression—the kind that would itself affect brain structure. "We cannot separate potential effects of medication from the effects of the more severe depression that medications are prescribed to treat," said Danielle Luu, the study's lead author. The team emphasized that their findings should not prompt anyone to stop taking prescribed medication.
The study drew from a diverse, community-based research initiative called HABS-HD, which examines Alzheimer's risk across Hispanic, non-Hispanic Black, and non-Hispanic White older adults. This diversity matters. It means the findings come from a substantially larger and more representative population than many previous studies of depression and brain aging. Yet the researchers were explicit about what they had not shown. The study does not prove that depression causes hippocampal shrinkage, nor does it establish that the observed differences will lead to Alzheimer's disease. What it does is point a spotlight at a specific brain region and suggest a new avenue for investigation. Arthur Toga, director of the Stevens INI, framed the implications carefully: understanding how depression relates to specific memory systems may help identify people at risk, clarify the pathways connecting depression and dementia, and ultimately guide more personalized approaches to protecting brain health. But that work lies ahead. Long-term studies that follow people before and after treatment, that track depression history and symptom severity, that measure medication type and dosage and duration—those studies will be essential. For now, the finding stands as a precise anatomical clue in a much larger puzzle.
Citas Notables
By looking closely at the individual parts of the hippocampus, we identified a specific area that may be particularly sensitive to depression in older adults.— Danielle Luu, study lead author
We cannot separate potential effects of medication from the effects of the more severe depression that medications are prescribed to treat.— Danielle Luu
Quieres la nota completa?
Lee el original en News-Medical ↗
Health & Medicine